drugset / Trial / NCT06940700

Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma

NCT06940700

Phase 2 Not yet recruiting 60 enrolled Guangdong Hengrui Pharmaceutical Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy and safety of SHR-4597 inhalants in adults with asthma: a multicenter, randomized, open-label, positive-controlled Phase II clinical study

Timeline

Start
2025-04
Primary completion
2025-10
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule
Subject SHR4597 Unknown

Indications